Michael Brobjer has long experience from leading positions in pharmaceutical and biotech companies, such as Pharmacia & Upjohn and Biovitrum. He has also held the position as Marketing Manager and Responsible for Business Life Science within APL, which offers companies contract services in Life Science, and now last CEO of Karessa and Karessa Holding. Michael has a strong profile focusing on leadership and communication. His experience in strategic development and corporate construction is well suited to the role of AroCell’s CEO.

“We are very pleased that Michael Brobjer is joining us as CEO. His solid experience of Life Science and enthusiastic leadership style will help to establish AroCell’s CE-labeled products on the market, as well as to develop the company’s clinical programs and commercialization strategy. With Michael as CEO together with the recent recruitment of Anders Hultman as CFO, the company will have an exciting and driven leadership duo ” said Claes Post, Chairman AroCell.

“I´m looking forward to start at AroCell. My assessment is that there is a great potential in the company and it feels really exciting to take part and lead the company’s continued development. AroCell has a technology that has the potential to contribute to increased benefit for both patients and healthcare providers through monitoring tumor development, “said Michael Brobjer.